CIK 0001501989
- Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273521219
- Phone
- +1 650-515-3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale Chief Financial Officer sold 8,551 shares at $0.60 ($5,122)
- 4 Open-market sale Chief Medical Officer sold 4,025 shares at $0.60 ($2,411)
- 4 Open-market sale General Counsel sold 10,203 shares at $0.60 ($6,112)
- 4 Open-market sale SVP, Chief Scientific Officer sold 19,512 shares at $0.60 ($11,688)
- 4/A Grant or award SVP, Chief Scientific Officer acquired 92,500 shares (grant or award)
- 4 Grant or award SVP, Chief Scientific Officer acquired 87,500 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 113,500 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 101,500 shares (grant or award)
- 4 Grant or award CEO acquired 375,000 shares (grant or award)
- 4 Open-market sale Chief Business Officer sold 4,181 shares at $1.23 ($5,139)
- 4 Open-market sale SVP, Chief Scientific Officer sold 4,181 shares at $1.23 ($5,139)
- 4 Open-market sale General Counsel sold 4,181 shares at $1.23 ($5,139)
- 4 Open-market sale Chief Financial Officer sold 1,984 shares at $1.23 ($2,439)
- 4 Open-market sale CEO sold 13,898 shares at $1.23 ($17,082)
- 4 Grant or award Chief Financial Officer acquired 17,500 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 20 · 400 filings